Ibotta, Inc.
IBTA NYSE Services-Advertising Financials FY2022βFY2025
What Ibotta, Inc. does
No business description yet.
- Legal name
- Ibotta, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001628280-26-011838
0001538379
Revenue and margins
Ibotta, Inc. had $342M of revenue in fiscal 2025, down 6.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $75.0M in fiscal 2025, 21.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ibotta, Inc. returned $233M to shareholders in fiscal 2025, 311% of free cash flow. The diluted share count rose 12.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Ibotta, Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $17.8M | $62.6M | $349M | $187M |
| Debt incl. finance leases | β | $64.4M | $0.0M | $0.0M |
| Net debt / EBITDA | β | 0.0x | β9.7x | β25.0x |
| Debt / equity | β | 2.3x | 0.0x | 0.0x |
| Interest coverage | β6.5x | 6.4x | 7.8x | β1.7x |
| Current ratio | β | 1.5x | 2.8x | 2.0x |
| Quick ratio | β | 1.5x | 2.8x | 2.0x |
| Total assets | β | $320M | $678M | $526M |
| Total liabilities | β | $292M | $221M | $238M |
| Shareholders' equity | β$34.8M | $27.9M | $457M | $288M |
| Net debt (β = net cash) | β | $1.9M | β$349M | β$187M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 5 | 7 / 9 | 4 / 9 |
| Accruals ratio | β | 4.8% | β9.5% | β15.2% |
| Altman Z'' | β | 1.20 | 5.42 | 2.91 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $211M | $320M | $367M | $342M |
| Gross profit | $165M | $276M | $317M | $271M |
| Research and development | $42.6M | $50.0M | $63.3M | $61.1M |
| Operating income | β$40.3M | $56.0M | $27.9M | β$0.8M |
| Interest expense | $6.2M | $8.8M | $3.6M | $0.5M |
| Pretax income | β$54.6M | $44.1M | $24.5M | $9.8M |
| Income tax | $0.3M | $5.9M | β$44.2M | $6.3M |
| Net income | β$54.9M | $38.1M | $68.7M | $3.6M |
| Diluted EPS | β$6.33 | $1.42 | $2.56 | $0.12 |
| Diluted shares | 0.01B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||
| Cash from operations | β$56.5M | $22.7M | $116M | $95.3M |
| Capital expenditure | $0.8M | $0.5M | $0.9M | $20.3M |
| Free cash flow | β$57.3M | $22.2M | $115M | $75.0M |
| Depreciation and amortization | $6.3M | $6.7M | $8.1M | $8.3M |
| Stock-based compensation | $6.5M | $7.0M | $46.9M | $44.1M |
| Share buybacks | $0.0M | $0.0M | $31.3M | $233M |
| Dividends and buybacks | $0.0M | $0.0M | $31.3M | $233M |
| Balance sheet | ||||
| Cash and short-term investments | $17.8M | $62.6M | $349M | $187M |
| Total debt | β | $64.4M | $0.0M | $0.0M |
| Current assets | β | $298M | $582M | $408M |
| Current liabilities | β | $198M | $204M | $208M |
| Property and equipment, net | β | $2.5M | $2.0M | $23.4M |
| Total assets | β | $320M | $678M | $526M |
| Total liabilities | β | $292M | $221M | $238M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β$34.8M | $27.9M | $457M | $288M |
| Margins | ||||
| Gross margin | 78.1% | 86.3% | 86.4% | 79.2% |
| Operating margin | β19.1% | 17.5% | 7.6% | β0.2% |
| EBITDA margin | β16.1% | 19.6% | 9.8% | 2.2% |
| Net margin | β26.0% | 11.9% | 18.7% | 1.0% |
| FCF margin | β27.2% | 6.9% | 31.3% | 21.9% |
| Returns | ||||
| Return on capital | β | 162.7% | 25.9% | β0.5% |
| Return on capital employed | β | 46.0% | 5.9% | β0.3% |
| Return on equity | β | β | 28.3% | 1.0% |
| Return on assets | β | 11.9% | 13.8% | 0.6% |
| Return on tangible equity | β | 136.5% | 15.0% | 1.2% |
| Growth | ||||
| Revenue growth | β | 51.9% | 14.8% | β6.8% |
| Net income growth | β | β | 80.3% | β94.8% |
| EPS growth | β | β | 80.3% | β95.3% |
| FCF growth | β | β | 419.0% | β34.8% |
| Share count change | β | 210.4% | β0.2% | 12.1% |
| Financial health | ||||
| Net debt / EBITDA | β | 0.0x | β9.7x | β25.0x |
| Debt / equity | β | 2.3x | 0.0x | 0.0x |
| Interest coverage | β6.5x | 6.4x | 7.8x | β1.7x |
| Current ratio | β | 1.5x | 2.8x | 2.0x |
| Quick ratio | β | 1.5x | 2.8x | 2.0x |
| Capital allocation | ||||
| Capex / revenue | 0.4% | 0.2% | 0.2% | 5.9% |
| Stock comp / revenue | 3.1% | 2.2% | 12.8% | 12.9% |
| Payouts / FCF | β | 0.0% | 27.2% | 310.7% |
| Quality scores | ||||
| Piotroski F-score | β | β | 7.0 | 4.0 |
| Altman Z'' | β | 1.2 | 5.4 | 2.9 |
| Accruals ratio | β | 4.8% | β9.5% | β15.2% |
Source: SEC EDGAR XBRL filings (CIK 0001538379). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.